Why We Started Bactera: Why Most Microbiome Tests Still Miss the Bigger Picture

The human gut microbiome has become one of the most talked-about topics in modern health science. Every year, thousands of new studies explore how the trillions of microorganisms living inside the gut may interact with nutrition, metabolism, immunity, lifestyle, and the broader human ecosystem.

At the same time, microbiome testing has become increasingly accessible. More people than ever are interested in understanding their gut microbiome, often through simple at-home tests promising personalized insights into bacterial composition and gut health.

But as fascinating as this field is, we believe there is an important problem that is rarely discussed openly:

Many microbiome analyses still capture only a small fraction of the microbial ecosystem.

And that realization was one of the reasons Bactera was created.

The Problem With Looking at the Microbiome Through a Keyhole

The gut microbiome is incredibly complex. It contains not only bacteria, but also viruses, bacteriophages, fungi, archaea, and millions of microbial genes interacting within a constantly changing ecosystem¹.

Yet many traditional microbiome tests still rely on relatively narrow analytical methods that focus primarily on selected bacterial marker regions. While these methods played an important role in microbiome research, they often provide only a limited snapshot of the broader microbial world.

To us, this felt a bit like trying to understand an entire rainforest by looking at a few leaves.

You may see part of the picture, but you miss the complexity of the ecosystem itself.

And in microbiome science, the ecosystem matters.

Why We Chose Shotgun Metagenomics

From the beginning, we wanted Bactera to focus on modern, research-driven microbiome analysis.

That is why we chose shotgun metagenomic sequencing as the foundation of our platform.

Unlike traditional targeted approaches, shotgun sequencing analyzes the total microbial DNA within a sample². Instead of focusing on only selected bacterial regions, it allows for a broader and more detailed view of the microbiome ecosystem.

This means the analysis can potentially include:

• bacterial diversity 

• species-level resolution 

• fungi and yeasts 

• viruses and bacteriophages 

• microbial functional potential 

• resistance-associated genes 

For us, this was not simply a technological upgrade.

It represented a different philosophy:
looking at the microbiome as a complex biological ecosystem rather than just a list of bacteria.

The Future of Microbiome Science Is About Ecosystems

One of the most exciting developments in microbiome research is the growing realization that microorganisms do not exist in isolation.

Bacteria interact with each other.
Viruses influence bacterial populations.
Diet shapes microbial communities.
Stress, sleep, antibiotics, and lifestyle continuously alter the ecosystem.

The microbiome behaves less like a static bacterial catalog and more like a dynamic living network³.

This is also why we believe future microbiome science will increasingly move beyond simple bacterial summaries toward:

• ecosystem-level analysis 

• functional interpretation 

• microbial interactions 

• systems biology approaches 

Modern sequencing technologies are finally making these kinds of insights more accessible than ever before.

We Believe Microbiome Testing Should Educate, Not Oversimplify

Another reason we started Bactera was frustration with how oversimplified microbiome communication often becomes.

The microbiome is still a young scientific field. Many relationships between microorganisms and human health are still being actively researched. Yet consumers are sometimes presented with extremely definitive conclusions from relatively limited data.

We believe a more honest and scientifically responsible approach is needed.

That means:

• focusing on transparency 

• clearly separating science from speculation 

• avoiding exaggerated promises 

• presenting microbiome insights in an educational and understandable way 

Our goal is not to reduce the microbiome to a simplistic “good bacteria vs bad bacteria” narrative.

Instead, we want to help people better understand the complexity of the microbial world living inside them.

Beyond Testing: Building a Microbiome Research Platform

For us, microbiome analysis is only one part of a much larger vision.

Bactera was founded not only as a microbiome testing company, but also as a long-term microbiome research platform focused on understanding microbial ecosystems more deeply.

Our broader interests include:

• gut microbiome sequencing 

• bacteriophage research 

• microbial ecosystem restoration 

• functional microbiome analysis 

• future microbiome-based therapeutic approaches 

We believe the next generation of microbiome science will come from integrating sequencing, bioinformatics, ecology, and systems biology, not from isolated bacterial lists alone.

Why This Matters

The human microbiome contains millions of microbial genes: vastly more genetic information than the human genome itself⁴.

We are only beginning to understand what this means.

Modern microbiome science still has many unanswered questions. But one thing is already clear:

The future of microbiome analysis will likely become increasingly high-resolution, ecosystem-focused, and data-driven.

That future is what inspired us to build Bactera.

Not because we think microbiome science already has all the answers, but because we believe we are only at the beginning of discovering the real complexity of the microbial world.

Scientific References

1. Huttenhower C et al. Structure, function and diversity of the healthy human microbiome. Nature. 2012. 

2. Quince C et al. Shotgun metagenomics, from sampling to analysis. Nat Biotechnol. 2017. 

3. Lloyd-Price J et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature. 2019. 

4. Qin J et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010.